A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis

Clinical trial NCT06149520 · COMPLETED

Trial details

NCT number: NCT06149520
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombolysis Symptomatic Proximal Deep Vein Thrombosis

Start date: 2024-01-15
Primary completion: 2025-10-07
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.